Renaissance Group’s Transmedics TMDX Stock Holding History

Renaissance Group’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.3M	Buy	93,543 +16,314	+21%	+$2.13M	0.39%	77
2025 Q4	$9.39M	Buy	77,229 +1,151	+2%	+$144K	0.38%	65
2025 Q3	$8.54M	Buy	+76,078	New	+$8.91M	0.32%	78
2025 Q1	–	Sell	-30,596	Closed	-$1.91M	–	259
2024 Q4	$1.91M	Buy	+30,596	New	+$2.85M	0.08%	155

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Group's TMDX Position: Q1 2026 in Review

Renaissance Group increased its Transmedics (TMDX) stake by 21% in Q1 2026, buying an estimated $2.13M and bringing the position to 93,543 shares worth $9.3M. The position accounts for 0.39% of the portfolio, ranked #77.

Renaissance Group first reported a position in TMDX in Q4 2024 and has held it in 4 quarters since. The position peaked at $9.39M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Renaissance Group held 93,543 shares of Transmedics worth $9.3M as of Q1 2026.
Renaissance Group bought 16,314 Transmedics shares in Q1 2026, an estimated $2.13M.
Transmedics made up 0.39% of Renaissance Group's portfolio in Q1 2026, its #77 holding.
Renaissance Group first reported a position in Transmedics in Q4 2024 and has held it in 4 quarters since.
Renaissance Group's Transmedics position peaked at $9.39M in Q4 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Renaissance Group's 13F filing for Q1 2026, filed 13 May 2026.